Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)

  1. Powles, T.
  2. Kockx, M.
  3. Rodriguez-Vida, A.
  4. Duran, I.
  5. Crabb, S.J.
  6. Van Der Heijden, M.S.
  7. Szabados, B.
  8. Pous, A.F.
  9. Gravis, G.
  10. Herranz, U.A.
  11. Protheroe, A.
  12. Ravaud, A.
  13. Maillet, D.
  14. Mendez, M.J.
  15. Suarez, C.
  16. Linch, M.
  17. Prendergast, A.
  18. van Dam, P.-J.
  19. Stanoeva, D.
  20. Daelemans, S.
  21. Mariathasan, S.
  22. Tea, J.S.
  23. Mousa, K.
  24. Banchereau, R.
  25. Castellano, D.
Journal:
Nature Medicine

ISSN: 1546-170X,  1078-8956

Year of publication: 2023

Type: Erratum

DOI: 10.1038/S41591-023-02312-9 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus